Next-gen device Emerging WellnessPro Infinity flagship device signals ongoing product evolution and potential for upsell to current WellnessPro Plus customers and new medical facilities seeking the latest bioelectronic pain relief solutions.

Clinical adoption FDA clearance and professional-grade positioning suggest opportunities to target clinics, researchers, athletic programs, and sports medicine facilities that require reliable, scientifically supported pain management devices.

Expand reach Global team of scientists and ongoing marketing events (including Facebook Live campaigns) indicate readiness for broader market education and partnerships with distributors, rehab centers, and medical training programs.

Mid-market fit Revenue range and company scale align with mid-market buyers (mid-sized clinics, physical therapy networks, chiropractic groups) that value cost-effective, scalable bioelectronic therapies.

Strategic partnerships A history of PR-driven product launches and wide industry exposure creates potential for co-branding with larger medical device manufacturers, research institutions, and sponsorships within athletic and wellness communities.